Advertisement

Rheumaderm pp 201-206 | Cite as

Reactive Arthritis

  • Andrew Keat
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 455)

Summary

Reactive arthritis is one of the spondyloarthropathy family of clinical syndromes. The clinical features are those shared by other members of the spondyloarthritis family, though it is distinguished by a clear relationship with a precipitating infection. Susceptibility to reactive arthritis is closely linked with the class 1 HLA allele B27; it is likely that all sub-types pre-dispose to this condition. The link between HLA B27 and infection is mirrored by the development of arthritis in HLA B27-transgenic rats. In this model, arthritis does not develop in animals maintained in a germ-free environment.

Infections of the gastrointestinal, genitourinary and respiratory tract appear to provoke reactive arthritis and a wide range of pathogens has now been implicated. Although mechanistic parallels may exist, reactive arthritis is distinguished from Lyme disease, rheumatic fever and Whipple’s disease by virtue of the distinct clinical features and the link with HLA B27. As in these conditions both antigens and DNA of several micro-organisms have been detected in joint material from patients with reactive arthritis. The role of such disseminated microbial elements in the provocation or maintenance of arthritis remains unclear. HLA B27-restricted T-cell responses to microbial antigens have been demonstrated and these may be important in disease pathogenesis. The importance of dissemination of bacteria from sites of mucosal infection and their deposition injoints has yet to be fully understood.

The role of antibiotic therapy in the treatment of reactive arthritis is being explored; in some circumstances, both the anti-inflammatory and anti-microbial effects of certain antibiotics appear to be valuable.

The term reactive arthritis should be seen as a transitory one, reflecting a concept which may itselfbe on the verge of replacement, as our understanding of the condition develops. Nevertheless it appropriately describes arthritis that is associated with demonstrable infection at a distant site without traditional evidence of sepsis at the affected joint(s).

Although several forms of disease could be described as “reactive”, particularly acute rheumatic fever, post-meningococcal septicaemia arthritis and Lyme disease, in clinical practice the term is restricted to an acute spondyloarthritis, usually, but not exclusively, linked to acute genitourinary or gastrointestinal infection. A proportion of patients fulfil criteria for Reiter’s Syndrome [1].

Keywords

Lyme Disease Chlamydia Trachomatis Rheumatic Fever Reactive Arthritis Acute Rheumatic Fever 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Willkins RF, Arnett FC, Bitter T, Calin A, Fisher L, Ford DK, Good AE & Masi AT. Reiter’s Syndrome. Evaluation of preliminary criteria for definite disease. Arthritis Rheum 24, 844–849. 1981CrossRefGoogle Scholar
  2. 2.
    Moll JMH, Haslock I, Macrae I, Wright V. Associations between ankylosing spondylitis, psoriatic arthritis, Reiter’s disease, the intestinal arthropathies and Behçet’s syndrome. Medicine (Baltimore) 53, 343–1974Google Scholar
  3. 3.
    Dougados M, Van der Linden S, Juhlin R, Huitfeldt B, Amor B, Calin A, Catz A, Dijkmans B, Olivieri I, Pasero G, Veys E, Zeidler H. The European spondylarthropathy study group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 34, 1218–1227. 1991PubMedCrossRefGoogle Scholar
  4. 4.
    Toivanen A. Reactive arthritis and Reiter’s syndrome: history and clinical features. Rheumatology, eds JH Klippel, PA Dieppe. Mosby, London 11, 1–8. 1997Google Scholar
  5. 5.
    Arnold MH, Tyndall A. Post-streptococcal reactive arthritis. Ann Rheum Dis 48, 686–688. 1989PubMedCrossRefGoogle Scholar
  6. 6.
    Fink CW. The role of the streptococcus in post-streptococcal reactive arthritis and childhood polyarthritis nodosa. J Rheumatol 18 (Suppl) 14–20. 1991Google Scholar
  7. 7.
    Bhopal RA, Thomas GO. Psittacosis presenting with Reiter’s Syndrome. Br Med J 284, 1606. 1982CrossRefGoogle Scholar
  8. 8.
    Saari R, Toivanen A. Chlamydia pneumoniae as a cause of reactive arthritis. Brit J Rheumatol 32, 1112. 1993CrossRefGoogle Scholar
  9. 9.
    Braun J, Laitko S, Treharne J, Eggens U, Wu P, Distler A, Sieper J. Chlamydia pneumoniae — a new causative agent of reactive arthritis and undifferentiated oligoarthritis.Google Scholar
  10. 10.
    Keat A. Reiter’s Syndrome and reactive arthritis in perspective. N Engl J Med 309, 1606–1615. 1983PubMedCrossRefGoogle Scholar
  11. 11.
    Silveira LH, Gutierrez F, Scopelitis E, Cuellar ML, Citera G & Espinoza LR. Chlamydia-induced reactive arthritis. Rheum Dis Clin N Amer 19, 351–362. 1993Google Scholar
  12. 12.
    Horowitz S, Horowitz J, Taylor-Robinson D, Sukenik S, Apte RN, Barr-David J, Thomas B, Gilroy C. Ureaplasma urealyticum in Reiter’s Syndrome. J Rheumatol 21, 877–882. 1994PubMedGoogle Scholar
  13. 13.
    Vittecoq O, Schaeverbeke T, Favre S, Daragon A, Biga N, Cambon-Michot C, Bébéar C & Le Loet X. Molecular diagnosis of Ureaplasma urealyticum in an immunocompetent patient with destructive reactive polyarthritis. Arthritis Rheum 40, 2084–2089. 1997PubMedCrossRefGoogle Scholar
  14. 14.
    Taylor-Robinson D, Thomas BJ, Furr PM, Keat AC. The association of Mycoplasma hominis with arthritis. Sex Trans Dis (Suppl) 10, 341–344. 1983Google Scholar
  15. 15.
    Taylor-Robinson D, Gilroy CB, Horowitz S, Horowitz J. Mycoplasma genitalium in the joints of two patients with arthritis. Eur J Clin Microbiol Infect Dis 13, 1066–1069. 1994PubMedCrossRefGoogle Scholar
  16. 16.
    Schaeverbeke T, Gilroy CB, Bébéar C, Dehais J, Taylor-Robinson D. Mycoplasma fermentans in joints of patients with rheumatoid arthritis and other joint disorders. Lancet 347, 1418. 1996CrossRefGoogle Scholar
  17. 17.
    Hughes RA, Keat AC. Reiter’s Syndrome and reactive arthritis: a current view. Semin Arthritis Rheum 24, 190–210. 1994PubMedCrossRefGoogle Scholar
  18. 18.
    Rahman MU, Hudson AP, Schumacher HR. Chlamydia and Reiter’s Syndrome (reactive arthritis). Rheum Dis Clin N Amer 18, 16–79. 1992Google Scholar
  19. 19.
    Bas S, Griffais R, Kvien TK, Glennas A, Melby K, Vischer TL. Amplification of plasmid and chromosome chlamydia DNA in synovial fluid of patients with reactive arthritis and undifferentiated seronegative oligoarthropathies. Arthritis Rheum 38, 1005–1013. 1995PubMedCrossRefGoogle Scholar
  20. 20.
    Branigan PJ, Gerard HC, Saaibi D, Hudson AP, Schumacher HR. Screening of synovial tissue versus fluid from patients with Reiter’s Syndrome (RS), other spondyloarthropathies or reactive arthritis (ReA) for chlamydia via polymerase chain reaction (PCR). Arthritis Rheum 38(R20). 1995Google Scholar
  21. 21.
    Bas S, Ninet B, Delaspre O, Vischer TL. Evaluation of commercially available tests for chlamydia nucleic acid detection in synovial fluid of patients. Brit J Rheumatol 36, 198–202. 1997CrossRefGoogle Scholar
  22. 22.
    Li F, Bulbul R, Schumacher HR, Kieber-Emmons T, Callegari PE, Von Feldt JM, Norden D, Freundlich B, Wang B, Imonitie V, Peichang C, Nachamkin I, Weiner DB, Williams VW. Molecular detection of bacterial DNA in venereal-associated arthritis. Arthritis Rheum 39, 950–958. 1996PubMedCrossRefGoogle Scholar
  23. 23.
    Lahesmaa-Rantala R, Granfors K, Isomaki H, Toivanen A. Yersinia-specific immune complexes in the synovial fluid of patients with Yersinia-triggered reactive arthritis. Ann Rheum Dis 46, 510=514. 1987Google Scholar
  24. 24.
    Hughes RA, Keat AC. Reactive arthritis: the role of bacterial antigens in inflammatory arthritis. Clin Rheum 6, 285–308. 1992Google Scholar
  25. 25.
    Sieper J, Braun J, Brandt J, Miksits K, Heesemann J, Laitko S, Sorenson H, Distler A, Langley G. Pathogenic role of Chlamydia, Yersinia and Borrelia in undifferentiated oligoarthritis. J Rheumatol 19 1236–1241. 1992PubMedGoogle Scholar
  26. 26.
    Ford DK, Da Roza DM, Schulzer M. Lymphocytes from the site of disease but not blood lymphocytes indicate the cause of arthritis. Ann Rheum Dis 44, 701. 1985PubMedCrossRefGoogle Scholar
  27. 27.
    Gaston JSH, Life PF, Granfors K, Merilahti-Palo R, Bailey L, Consalvey S, Toivanen A, Bacon PA. Synovial T-lymphocyte recognition of organisms that trigger reactive arthritis. Clin Exp Immunol 76, 348–353. 1989PubMedGoogle Scholar
  28. 28.
    Sieper J, Kingsley G, Palacios-Boix A et al. Synovial T-lymphocyte-specific immmune response to Chlamydia trachomatis in Reiter’s disease. Arthritis Rheum 34, 588–598. 1991PubMedCrossRefGoogle Scholar
  29. 29.
    Hermann E, Yu DT, Meyer zum Buschenfelde KH, Fleischer B. HLA-B27-restricted CD8 T-cells derived from synovial fluids of patients with reactive arthritis and ankylosing spondylitis. Lancet 342, 646–650. 1993PubMedCrossRefGoogle Scholar
  30. 30.
    Pelton BK, Harvey AR, Denman AM. The rheumatoid synovial membrane participates in systemic anti-viral immune responses. Clin Exp Immunol 62, 657–661. 1985PubMedGoogle Scholar
  31. 31.
    Stagg AJ, Hughes RA, Keat ACS, Elsley WA, Knight SC. Antigen-presenting cells but not lymphocytes in the joint may indicate the cause of reactive arthritis. Brit J Rheum 35, 1082–1090. 1996CrossRefGoogle Scholar
  32. 32.
    Lauhio A, Leirisalo-Repo M, Lahdevirta J, Saikku P, Repo H. Double-blind, placebo-controlled study of three months treament with lymecycline in reactive arthritis, with special reference to Chlamydia arthritis. A rthritis Rheum 34, 6–14. 1991CrossRefGoogle Scholar
  33. 33.
    Toivanen A, Yli-Kertulta T, Luukkainen R et al. Effect of antimicrobial treatment of chronic reactive arthritis. Clin Exp Rheumatol 11, 301–307. 1993PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1999

Authors and Affiliations

  • Andrew Keat
    • 1
  1. 1.Department of RheumatologyNorthwick Park and St Mark’s HospitalsMiddlesexUK

Personalised recommendations